Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer

Perkins, 2007, Why current breast pathology practices must be evaluated. A Susan G. Komen for the Cure white paper: June 2006, Breast J, 13, 443, 10.1111/j.1524-4741.2007.00463.x Hass, 2008, The worldwide epidemiology of prostate cancer: perspectives from autopsy studies, Can J Urol, 15, 3866 Kong, 2012, microRNAs in cancer management, Lancet Oncol, 13, e249, 10.1016/S1470-2045(12)70073-6 Bartel, 2004, Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs, Nat Rev Genet, 5, 396, 10.1038/nrg1328 Ambros, 2004, The functions of animal microRNAs, Nature, 431, 350, 10.1038/nature02871 MacFarlane, 2010, MicroRNA: biogenesis, function and role in cancer, Curr Genomics, 11, 537, 10.2174/138920210793175895 Bushati, 2007, microRNA functions, Annu Rev Cell Dev Biol, 23, 175, 10.1146/annurev.cellbio.23.090506.123406 Stefani, 2012, A “pivotal” new rule for microRNA-mRNA interactions, Nat Struct Mol Biol, 19, 265, 10.1038/nsmb.2256 Piletič, 2016, MicroRNA epigenetic signatures in human disease, Arch Toxicol, 10.1007/s00204-016-1815-7 Bonci, 2015, A predictive signature for therapy assignment and risk assessment in prostate cancer, Oncoscience, 2, 920, 10.18632/oncoscience.271 Flatmark, 2016, microRNAs as cancer biomarkers, Scand J Clin Lab Invest Suppl, 245, S80, 10.1080/00365513.2016.1210330 Coarfa, 2016, Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer, Clin Chem Lab Med Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, 19, 92, 10.1101/gr.082701.108 Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing, Nature, 425, 415, 10.1038/nature01957 Han, 2004, The Drosha-DGCR8 complex in primary microRNA processing, Genes Dev, 18, 3016, 10.1101/gad.1262504 Hutvagner, 2001, A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA, Science, 293, 834, 10.1126/science.1062961 Pillai, 2007, Repression of protein synthesis by miRNAs: how many mechanisms?, Trends Cell Biol, 17, 118, 10.1016/j.tcb.2006.12.007 Liu, 2008, Control of protein synthesis and mRNA degradation by microRNAs, Curr Opin Cell Biol, 20, 214, 10.1016/j.ceb.2008.01.006 Sharova, 2016, A circulating miRNA assay as a first-line test for prostate cancer screening, Br J Cancer, 114, 1362, 10.1038/bjc.2016.151 Kouriefs, 2009, Prostate Specific Antigen through the Years, Arch Ital Urol Androl, 81, 195 Greene, 2013, Prostate specific antigen best practice statement: 2009 update, Am Urol Assoc J Urol, 189, S2 Cooperberg, 2011, The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy, Cancer, 117, 5039, 10.1002/cncr.26169 Turo, 2015, Do prostate cancer nomograms give accurate information when applied to European patients?, Scand J Urol, 49, 16, 10.3109/21681805.2014.920415 Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 13, 1320, 10.1056/NEJMoa0810084 Stuopelytė, 2016, Detection of miRNAs in urine of prostate cancer patients, Medicina (Kaunas), 52, 116, 10.1016/j.medici.2016.02.007 Gonzales, 2011, Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer, Clin Genitourin Cancer, 1, 39, 10.1016/j.clgc.2011.05.008 Leidinger, 2016, Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status, Tumour Biol, 37, 10177, 10.1007/s13277-016-4883-7 Kojima, 2016, The roles of microRNAs in the progression of castration-resistant prostate cancer, J Hum Genet Filella, 2016, miRNAs as novel biomarkers in the management of prostate cancer, Clin Chem Lab Med, 10.1515/cclm-2015-1073 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A, 105, 10513, 10.1073/pnas.0804549105 Brase, 2011, Circulating miRNAs are correlated with tumor progression in prostate cancer, Int J Cancer, 128, 608, 10.1002/ijc.25376 Bryant, 2012, Changes in circulating microRNA levels associated with prostate cancer, Br J Cancer, 106, 768, 10.1038/bjc.2011.595 Yaman, 2011, Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer, Tumour Biol, 32, 583, 10.1007/s13277-011-0154-9 Moltzahn, 2011, Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients, Cancer Res, 71, 550, 10.1158/0008-5472.CAN-10-1229 Shen, 2012, Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer, Prostate, 72, 10.1002/pros.22499 Mahn, 2011, Circulating microRNAs (miRNA) in serum of patients with prostate cancer, Urology, 77, 10.1016/j.urology.2011.01.020 Mattie, 2006, Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies, Mol Cancer, 5, 24, 10.1186/1476-4598-5-24 Porkka, 2007, MicroRNA expression profiling in prostate cancer, Cancer Res, 67, 6130, 10.1158/0008-5472.CAN-07-0533 Shi, 2008, MicroRNAs and prostate cancer, J Cell Mol Med, 12, 1456, 10.1111/j.1582-4934.2008.00420.x Tong, 2009, MicroRNA profile analysis of human prostate cancers, Cancer Gene Ther, 16, 206, 10.1038/cgt.2008.77 Schaefer, 2010, Int J Cancer, 126, 1166 Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci U S A, 103, 2257, 10.1073/pnas.0510565103 Ambs, 2008, Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Res, 68, 6162, 10.1158/0008-5472.CAN-08-0144 Szczyrba, 2010, The microRNA profile of prostate carcinoma obtained by deep sequencing, Mol Cancer Res, 8, 529, 10.1158/1541-7786.MCR-09-0443 Gloria, 2016, MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer, Int J Mol Sci, 17, 421, 10.3390/ijms17030421 Kato, 2005, Function of nuclear sex hormone receptors in gene regulation, Cancer Chemother Pharmacol, 56, 4, 10.1007/s00280-005-0102-8 Michael, 2014, AR function in promoting metastatic prostate cancer, Cancer Metastasis Rev, 33, 399, 10.1007/s10555-013-9471-3 Chen, 2004, Molecular determinants of resistance to antiandrogen therapy, Nat Med, 10, 33, 10.1038/nm972 Ribas, 2010, The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer, Cell Cycle, 9, 923, 10.4161/cc.9.5.10930 Fujii, 2016, Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer, Mol Carcinog, 55, 1378, 10.1002/mc.22381 Tome-Garcia, 2014, ERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells, PLoS One, 9, e99525, 10.1371/journal.pone.0099525 Henttu, 1993, Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP, Cancer Res, 53, 1051 Fletcher, 2012, Androgen-regulated processing of the oncomir miR-27a, which targets prohibitin in prostate cancer, Hum Mol Genet, 21, 3112, 10.1093/hmg/dds139 Bonci, 2008, The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities, Nat Med, 14, 1271, 10.1038/nm.1880 Felekkis, 2010, Stefanou Ch, Deltas C. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease, Hippokratia, 14, 236 Alshalalfa, 2012, MicroRNA response elements-mediated miRNA-miRNA interactions in prostate cancer, Adv Bioinformatics, 2012, 839837, 10.1155/2012/839837 Li, 2012, Suppression of CX43 expression by miR-20a in the progression of human prostate cancer, Cancer Biol Ther, 13, 890, 10.4161/cbt.20841 Garzon, 2009, MicroRNAs in Cancer, Annu Rev Med, 60, 167, 10.1146/annurev.med.59.053006.104707 Majid, 2013, MiRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways, Clin Cancer Res, 19, 73, 10.1158/1078-0432.CCR-12-2952 Shaniece, 2014, MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase, Oncotarget, 5, 3512, 10.18632/oncotarget.1953 Hock, 2012, A complex Polycomb issue: the two faces of EZH2 in cancer, Genes Dev, 26, 751, 10.1101/gad.191163.112 Cao, 2011, Coordinated regulation of polycomb group complexes through microRNAs in cancer, Cancer Cell, 20, 187, 10.1016/j.ccr.2011.06.016 Poliseno, 2010, A coding-independent function of gene and pseudogene mRNAs regulates tumour biology, Nature, 465, 1033, 10.1038/nature09144 Erdmann, 2014, Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs, BMC Cancer, 14, 82, 10.1186/1471-2407-14-82 Koh, 2011, Myc enforces over expression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms, Oncotarget, 2, 669, 10.18632/oncotarget.327 Xiang, 2013, PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer, Biomaterials, 34, 6976, 10.1016/j.biomaterials.2013.05.055 Qiang, 2014, MiR-20a promotes prostate cancer invasion and migration through targeting ABL2, J Cell Biochem, 115, 1269, 10.1002/jcb.24778 Zhang, 2011, Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy, Prostate, 71, 326, 10.1002/pros.21246 Endzeliņš, 2016, Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review, Mol Cancer, 15, 41, 10.1186/s12943-016-0523-5 Liu, 2011, MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression, PLoS One, 6, e19139, 10.1371/journal.pone.0019139 Tong, 2009, The role of microRNA-221 and -222 in androgen-independent prostate cancer cell lines, Cancer Res, 69, 3356, 10.1158/0008-5472.CAN-08-4112 Xinsheng, 2011, Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT, PLoS One, 6, e20341, 10.1371/journal.pone.0020341 Lee, 2009, MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells, Clin Cancer Res, 15, 5126, 10.1158/1078-0432.CCR-09-0051 Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci U S A, 101, 2999, 10.1073/pnas.0307323101 Selth, 2012, Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease, Int J Cancer., 131, 652, 10.1002/ijc.26405